Consistently, flow cytometry data also revealed the significantly higher positive expression rate (6.9 ± 0.34% vs. 1.60 ± 0.26%) of IL-17A in TILs of NSCLC specimens than those of controls (p < 0.0001, Figure 1B). This evidence concerns the gene IL17A and non-small cell lung carcinoma.